No Benefit With CRT Versus RT in Cervical Cancer After Radical Hysterectomy

MedPage Today) -- The addition of concurrent cisplatin chemotherapy to adjuvant radiation therapy (CRT), versus RT alone, couldn't move the needle on outcomes in patients with cervical cancer who had intermediate risk factors after radical hysterectomy...

Market Touch Signal is a free discovery window from Oy Market Touch Ltd. Practical intelligence, clear communication and useful digital ventures: https://market-touch.org/
Get In Touch

Market Touch Signal · Finland · international digital desk

+358 400 512311

info@market-touch.org

Follow Us
Flickr Photos
© 2026 Oy Market Touch Ltd. · Market Touch Signal